|
| 1 | +#' Dataset of targeted and non-targeted cancer drugs |
| 2 | +#' |
| 3 | +#' A dataset containing an extensive collection of anti-cancer drugs, i.e. targeted compounds, chemotherapy regimens etc. The |
| 4 | +#' data has been harvested from the Open Targets Platform, the NCI Thesaurus, and ChEMBL. Note that each entry corresponds |
| 5 | +#' to a "drug synonym-target-indication association" |
| 6 | +#' |
| 7 | +#' @format \bold{oncopharmadb} - A data frame with 418,620 rows and 49 columns: |
| 8 | +#' \itemize{ |
| 9 | +#' \item \emph{drug_name} - Primary drug name (upper case, NCI Thesaurus) |
| 10 | +#' \item \emph{nci_concept_display_name} - Primary drug name (NCI Thesaurus) |
| 11 | +#' \item \emph{drug_type} - type of drug molecule (Antibody, small molecule etc) |
| 12 | +#' \item \emph{drug_action_type} - main action elicited by drug (antagonist, inhibitor, stabiliser etc) |
| 13 | +#' \item \emph{molecule_chembl_id} - ChEMBL compound identifier |
| 14 | +#' \item \emph{drug_max_phase_indication} - maximum clinical phase for drug (given indication) |
| 15 | +#' \item \emph{drug_max_ct_phase} - maximum clinical phase for drug (any indication) |
| 16 | +#' \item \emph{target_genename} - name/description of drug target |
| 17 | +#' \item \emph{target_symbol} - symbol of drug target |
| 18 | +#' \item \emph{target_type} - type of drug target (single protein, protein family etc.) |
| 19 | +#' \item \emph{target_ensembl_gene_id} - Ensembl gene identifier of drug target |
| 20 | +#' \item \emph{target_entrezgene} - Entrez gene identifier of drug target |
| 21 | +#' \item \emph{target_uniprot_id} - UniProt identifier of drug target |
| 22 | +#' \item \emph{disease_efo_id} - EFO (Experimental Factor Ontology) identifier for drug indication |
| 23 | +#' \item \emph{disease_efo_label} - EFO (Experimental Factor Ontology) label for drug indication |
| 24 | +#' \item \emph{cui} - UMLS metathesaurus identifier (concept unique identifier) for drug indication |
| 25 | +#' \item \emph{cui_name} - UMLS metahesaurus name for drug indication |
| 26 | +#' \item \emph{primary_site} - primary tumor site/type (obtained through https://github.com/sigven/oncoPhenoMap) |
| 27 | +#' \item \emph{nci_concept_synonym} - drug synonym (NCI, Open Targets Platform) |
| 28 | +#' \item \emph{nci_concept_synonym_all} - all drug synonyms (NCI Thesurus, Open Targets Platform) |
| 29 | +#' \item \emph{drug_clinical_source} - underlying source for drug entry (DailyMed, clinicaltrials.gov, FDA etc.) |
| 30 | +#' \item \emph{drug_approved_indication} - logical indicating if drug has an approved indication |
| 31 | +#' \item \emph{drug_blacbox_warning} - logical indicating if drug has blackbox warning |
| 32 | +#' \item \emph{drug_year_first_approval} - year drug was first approved |
| 33 | +#' \item \emph{drug_clinical_id} - drug clinical identifier (clinicaltrials.gov, DailyMed, FDA etc.) |
| 34 | +#' \item \emph{nci_t} - NCI Thesaurus identifier |
| 35 | +#' \item \emph{nci_concept_definition} - detailed description of drug mechanism-of-action (NCI Thesaurus) |
| 36 | +#' \item \emph{nci_version} - version of NCI used for this version of oncoPharmaDB |
| 37 | +#' \item \emph{chembl_version} - version of ChEMBL used for this version of oncoPharmaDB |
| 38 | +#' \item \emph{opentargets_version} - version of Open Target Platform used for this version of oncoPharmaDB |
| 39 | +#' \item \emph{comb_regimen_indication} - type of drug molecule (Antibody, small molecule etc) |
| 40 | +#' \item \emph{immune_checkpoint_inhibitor} - logical indicating if drug is an immune checkpoint inhibitor |
| 41 | +#' \item \emph{topoisomerase_inhibitor} - logical indicating if drug is a topoisomerase inhibitor |
| 42 | +#' \item \emph{tubulin_inhibitor} - logical indicating if drug is a tubulin inhibitor |
| 43 | +#' \item \emph{kinase_inhibitor} - logical indicating if drug is a kinase inhibitor |
| 44 | +#' \item \emph{hdac_inhibitor} - logical indicating if drug is a HDAC inhibitor |
| 45 | +#' \item \emph{parp_inhibitor} - logical indicating if drug is a PARP inhibitor |
| 46 | +#' \item \emph{bet_inhibitor} - logical indicating if drug is a BET inhibitor |
| 47 | +#' \item \emph{ar_antagonist} - logical indicating if drug is an androgen receptor antagonist |
| 48 | +#' \item \emph{monoclonal_antibody} - logical indicating if drug is an antibody |
| 49 | +#' \item \emph{antimetabolite} - logical indicating if drug is an antimetabolite |
| 50 | +#' \item \emph{angiogenesis_inhibitor} - logical indicating if drug is an angiogenesis inhibitor |
| 51 | +#' \item \emph{alkylating_agent} - logical indicating if drug is an alkylating agent |
| 52 | +#' \item \emph{platinum_compound} - logical indicating if drug is a platinum compound |
| 53 | +#' \item \emph{anthracycline} - logical indicating if drug is an anthracycline |
| 54 | +#' \item \emph{proteasome_inhibitor} - logical indicating if drug is a proteasome inhibitor |
| 55 | +#' \item \emph{hormone_therapy} - logical indicating if drug is a hormone therapy |
| 56 | +#' \item \emph{hedgehog_antagonist} - logical indicating if drug is a hedgehog pathway antagonist |
| 57 | +#' } |
| 58 | +#' |
| 59 | +#' |
| 60 | +#' @source \url{https://targetvalidation.org/} |
| 61 | +#' @source \url{https://www.ebi.ac.uk/chembl/} |
| 62 | +#' @source \url{https://ncithesaurus.nci.nih.gov/ncitbrowser/} |
| 63 | +"oncopharmadb" |
| 64 | + |
| 65 | +#' Dataset of drug synonyms - linking known drug aliases to a primary identifier |
| 66 | +#' |
| 67 | +#' @format \bold{oncopharma_synonyms} - A data frame with 9,946 rows and 52 columns: |
| 68 | +#' \itemize{ |
| 69 | +#' \item \emph{alias} - drug alias |
| 70 | +#' \item \emph{nci_concept_display_name} - Primary drug name (NCI Thesaurus) |
| 71 | +#' \item \emph{molecule_chembl_id} - ChEMBL compound identifier |
| 72 | +#' } |
| 73 | +#' |
| 74 | +#' @source \url{https://targetvalidation.org/} |
| 75 | +#' @source \url{https://www.ebi.ac.uk/chembl/} |
| 76 | +#' @source \url{https://ncithesaurus.nci.nih.gov/ncitbrowser/} |
| 77 | +"oncopharma_synonyms" |
0 commit comments